Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 250, Issue -, Pages 115186
Publisher
Elsevier BV
Online
2023-02-07
DOI
10.1016/j.ejmech.2023.115186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
- (2022) Julia M Flynn et al. eLife
- A reporter cell line for the automated quantification of SARS-CoV-2 infection in living cells
- (2022) Lowiese Desmarets et al. Frontiers in Microbiology
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
- (2021) Sang Hoon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
- (2021) Chun-Hui Zhang et al. ACS Medicinal Chemistry Letters
- NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment
- (2021) François‐Xavier Cantrelle et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Perspectives on SARS-CoV-2 Main Protease Inhibitors
- (2021) Kaifu Gao et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease
- (2020) Hao Wang et al. ACS Catalysis
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
- (2020) Lifeng Fu et al. Nature Communications
- Advances in developing small molecule SARS 3CLpro inhibitors as potential remedy for corona virus infection
- (2020) Manashjyoti Konwar et al. TETRAHEDRON
- Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Alina Shitrit et al. Scientific Reports
- MXCuBE2: the dawn of MXCuBE Collaboration
- (2019) Marcus Oscarsson et al. JOURNAL OF SYNCHROTRON RADIATION
- CCP4i2: the new graphical user interface to the CCP4 program suite
- (2018) Liz Potterton et al. Acta Crystallographica Section D-Structural Biology
- Status of the crystallography beamlines at synchrotron SOLEIL⋆
- (2017) A. Coati et al. European Physical Journal Plus
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro)
- (2015) Sakshi Tomar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
- (2014) Woonghee Lee et al. BIOINFORMATICS
- Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
- (2013) Hyun Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group
- (2013) Lucie Maingot et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reducing agents affect inhibitory activities of compounds: Results from multiple drug targets
- (2012) Hyun Lee et al. ANALYTICAL BIOCHEMISTRY
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
- (2012) Jon Jacobs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started